Skip to main content
Premium Trial:

Request an Annual Quote

MacVector 6.0 Lauded As Most Significant Software Development of 1997

Premium

OXFORD--MacVector 6.0, the latest version of Oxford Molecular Group's popular Macintosh-platform bioinformatics software, has received a 1997 Most Signifi cant Development Award from the Biotechnology Software and Internet Journal, in recognition of its continued integration of internet databases. Journal editor Kevin Ahern noted, "MacVector is charting out new territory where other packages are afraid to tread. We ap plaud the developers of MacVector 6.0 for their commitment to internet molecular biology computing."

Among the key features of the new version of the software that qualified it for the award are extensions to its intuitive interface that shorten the learning curve for new users; internet access to sequence databases that doesn't require database maintenance or the use of a Unix interface; the fact that it provides researchers with all necessary sequence analysis tools in a single package; and seamless movement of information within the package.

Filed under

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.